U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263152) titled 'QTc Assessment in a Single-Dose Study of Hydronidone Capsules' on Nov. 23.
Brief Summary: This study was designed with three dose cohorts (A1-A3): a 90 mg cohort, a 270 mg cohort, and a 540 mg cohort. Each cohort enrolled 16 healthy Chinese participants, with 12 receiving the investigational product Hydronidone Capsules and 4 receiving placebo (i.e., matching placebo for Hydronidone Capsules). A total of 48 healthy Chinese subjects were planned for enrollment, and all participants received a single dose under fasting conditions.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Hepatic Fibrosis
Intervention:
DRUG:...